Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia

Leukemia Research

Volumn 34, Issue 1, 2010, Pages 18-23

  Yang, Yung Li ^a   Lin, Shu Rung ^b   Chen, Jiann Shiuh ^a,f   Lin, Shu Wha ^a,c   Yu, Sung Liang ^a,c   Chen, Hsuan Yu ^d   Yen, Ching Tzu ^c   Lin, Chien Yu ^d   Lin, Jing Fang ^c   Lin, Kai Hsin ^a   Jou, Shiann Tarng ^a   Hu, Chung Yi ^c   Chang, Sheng Kai ^c   Lu, Meng Yao ^a   Chang, Hsiu Hao ^a   Chang, Wan Hui ^e   Lin, Kuo Sin ^e   Lin, Dong Tsamn ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^e Childhood Cancer Foundation   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

BCL2L13; CASP8AP2; Childhood acute lymphoblastic leukemia (ALL); Livin

Indexed keywords

CASPASE 8 ASSOCIATED PROTEIN 2; GENE PRODUCT; LIVIN; PROTEIN BCL2L13; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; INFANT; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALCIUM-BINDING PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INHIBITOR OF APOPTOSIS PROTEINS; MALE; NEOPLASM PROTEINS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 73249114293     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.07.023     Document Type: Article

References (27)

1. Holleman A., den Boer M.L., Kazemier K.M., Janka-Schaub G.E., and Pieters R. Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood 102 (2003) 4541-4546
2. Flotho C., Coustan-Smith E., Pei D., et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 110 (2007) 1271-1277
3. Pui C.H., and Evans W.E. Treatment of acute lymphoblastic leukemia. N Engl J Med 354 (2006) 166-178
4. Pui C.H., Robison L.L., and Look A.T. Acute lymphoblastic leukaemia. Lancet 371 (2008) 1030-1043
5. Holleman A., den Boer M.L., de Menezes R.X., et al. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood 107 (2006) 769-776
6. Flotho C., Coustan-Smith E., Pei D., et al. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2. Blood 108 (2006) 1050-1057
7. Choi J., Hwang Y.K., Sung K.W., et al. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 109 (2007) 471-477
8. Liang D.C., Hung I.J., Yang C.P., et al. Unexpected mortality from the use of E. coli l-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group. Leukemia 13 (1999) 155-160
9. Lin W.Y., Liu H.C., Yeh T.C., Wang L.Y., and Liang D.C. Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 50 (2008) 523-527
10. Yu I.S., Lin S.R., Huang C.C., et al. TXAS-deleted mice exhibit normal thrombopoiesis, defective hemostasis, and resistance to arachidonate-induced death. Blood 104 (2004) 135-142
11. Kataoka T., Holler N., Micheau O., et al. Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. J Biol Chem 276 (2001) 19548-19554
12. Benedict M.A., Hu Y., Inohara N., and Nunez G. Expression and functional analysis of Apaf-1 Isoforms. Extra WD-40 repeat is required for cytochrome c binding and regulated activation of procaspase-9. J Biol Chem 275 (2000) 8461-8468
13. Seol D.-W., and Billiar T.R. A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J Biol Chem 274 (1999) 2072-2076
14. Nachmias B., Ashhab Y., Bucholtz V., et al. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. Cancer Res 63 (2003) 6340-6349
15. Moos P.J., Raetz E.A., Carlson M.A., et al. Identification of gene expression profiles that segregate patients with childhood leukemia. Clin Cancer Res 8 (2002) 3118-3130
16. Fine B.M., Stanulla M., Schrappe M., et al. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood 103 (2004) 1043-1049
17. Ross M.E., Zhou X., Song G., et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102 (2003) 2951-2959
18. Yeoh E.J., Ross M.E., Shurtleff S.A., et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1 (2002) 133-143
19. Ferrando A.A., Neuberg D.S., Staunton J., et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1 (2002) 75-87
20. Holleman A., Cheok M.H., den Boer M.L., et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 351 (2004) 533-542
21. Lugthart S., Cheok M.H., den Boer M.L., et al. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell 7 (2005) 375-386
22. Catchpoole D., Guo D., Jiang H., and Biesheuvel C. Predicting outcome in childhood acute lymphoblastic leukemia using gene expression profiling: Prognostication or protocol selection?. Blood 111 (2008) 2486-a-2487-a
23. Flotho C., Coustan-Smith E., Pei D., et al. A set of genes that regulate cell proliferation predict treatment outcome in childhood acute lymphoblastic leukemia. Blood (2007)
24. Loh M.L., Goldwasser M.A., Silverman L.B., et al. Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01. Blood 107 (2006) 4508-4513
25. Rubnitz J.E., Wichlan D., Devidas M., et al. Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. J Clin Oncol 26 (2008) 2186-2191
26. Cario G., Stanulla M., Fine B.M., et al. Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. Blood 105 (2005) 821-826
27. Chiaretti S., Li X., Gentleman R., et al. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood 103 (2004) 2771-2778